Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: A historical prospective study

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Schmilovitz Weiss, Hemda ^a   Tobar, Ana ^a   Halpern, Marisa ^a   Levy, Izhar ^b   Shabtai, Esther ^c   Ben Ari, Ziv ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

Hepatocellular carcinoma; Immunostaining; Ki67; Squamous cellular carcinoma antigen; TUNEL assay

Indexed keywords

KI 67 ANTIGEN; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

AREA UNDER THE CURVE; ARTICLE; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NICK END LABELING; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

ANTIGENS, NEOPLASM; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; ROC CURVE; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 82755162458     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-121     Document Type: Article

References (19)

1. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008, 1:S20-S37.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
3. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745-750. 10.1056/NEJM199903113401001, 10072408.
4. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, Morabito A, De Franchis R, Colombo M. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004, 126:1005-1014. 10.1053/j.gastro.2003.12.049, 15057740.
5. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995, 22:432-438.
6. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917. 10.1016/S0140-6736(03)14964-1, 14667750.
7. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. 10.1002/hep.20933, 16250051.
8. Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 2005, 103:307-312. 10.1002/cncr.20774, 15593087.
9. D'Errico A, Grigioni WF, Fiorentino M, Baccarini P, Grazi GL, Mancini AM. Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: an immuno-histochemical study on 109 Italian patients. Pathol Int 1994, 44:682-687.
10. Fabregat I. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol 2009, 15:513-520. 10.3748/wjg.15.513, 2653340, 19195051.
11. Suminami Y, Kishi F, Sekiguchi K, Kato H. Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 1991, 181:51-58. 10.1016/S0006-291X(05)81380-4, 1958219.
12. Torre GC. SCC antigen in malignant and nonmalignant squamous lesions. Tumour Biol 1998, 19:517-526. 10.1159/000030045, 9817981.
13. Giannelli G, Marinosci F, Sgarra C, Lupo L, Dentico P, Antonaci S. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma. Int J Cancer 2005, 116:579-583. 10.1002/ijc.20847, 15825162.
14. Pontisso P, Calabrese F, Benvegnù L, Lise M, Belluco C, Ruvoletto MG, Marino M, Valente M, Nitti D, Gatta A, Fassina G. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 2004, 90:833-837. 10.1038/sj.bjc.6601543, 2410161, 14970861.
15. Guido M, Roskams T, Pontisso P, Fassan M, Thung SN, Giacomelli L, Sergio A, Farinati F, Cillo U, Rugge M. Squamous cell carcinoma antigen in human liver carcinogenesis. J Clin Pathol 2008, 61:445-447. 10.1136/jcp.2007.051383, 17893121.
16. Suminami Y, Nagashima S, Vujanovic NL, Hirabayashi K, Kato H, Whiteside TL. Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen. Br J Cancer 2000, 82:981-989. 10.1054/bjoc.1999.1028, 2374407, 10732775.
17. Kato H. Squamous cell carcinoma antigen. Serological Cancer Markers 1992, 437-451. Totowa: Humana Press, Sell S.
18. Watanabe J, Kushihata F, Honda K, Sugita A, Tateishi N, Mominoki K, Matsuda S, Kobayashi N. Prognostic significance of Bcl-xL in human hepatocellular carcinoma. Surgery 2004, 135:604-612. 10.1016/j.surg.2003.11.015, 15179366.
19. Trerotoli P, Fransvea E, Angelotti U, Trerotoli P, Fransvea E, Angelotti U, Antonaci G, Lupo L, Mazzocca A, Mangia A, Antonaci S, Giannelli G. Tissue expression of squamous cellular carcinoma antigen (SCCA) is inversely correlated to tumor size in HCC. Mol Cancer 2009, 8:29. 10.1186/1476-4598-8-29, 2693114, 19473531.